Whanin's strengths

• 

  Dedicated to CNS disease

  • No.1 in Psychiatric Sector with about 20% market share
  • Strong network among KOLs and specialists in psychiatry
  • Proven track record of commercial success

• 

  Fully integrated company

  • Core competencies in research, development, manufacturing, marketing and sales
  • Experienced expertise of in-license development

• 

  Flexible, fast decision making on partnerships

Whanin’s interests

• Strengthening CNS Portfolio
• Expanding our pipeline in various therapeutic areas, through marketing alliance, in-licensing, and investment.

Business Partnership